CION Ameerpet
Treatment Guide · Reviewed by CION Oncologists · NABH Accredited
Clinical Trials for Cervical Cancer — What They Are, and Who They Suit
A clinical trial is not a gamble with your treatment and it is not a last resort. It is a carefully governed study that compares a new approach against the current standard, run under ethics committee approval, with written consent and the right to walk away at any point. Most women who ask about trials are looking at advanced or recurrent disease, where newer approaches are being actively studied — but trials also exist in early disease, and there they usually test whether treatment can be made smaller and safer rather than bigger. This page explains how trials work in India, how to check what is genuinely recruiting, and the questions worth asking before you sign anything.
- You never give up standard care — in cancer trials the comparison arm is the best available treatment, not nothing
- Trials in India are publicly registered — the CTRI registry lets you look up a study yourself before you agree to it
- You can leave at any time — withdrawing does not cost you your right to standard treatment and follow-up
- 45-minute consultation — to review your reports and say honestly whether a trial is a realistic option for you
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
What a Clinical Trial Actually Is
A clinical trial is a planned study that tests a specific question in people, using a protocol written in advance. The protocol sets out exactly who can join, what will be given, what will be measured, how often you will be seen, and what triggers stopping. Nothing in it is improvised, and none of it can begin until an independent ethics committee has approved it.
Two myths get in the way of a sensible conversation. The first is that a trial means being experimented on with no safety net — in reality, participants in cancer trials are usually monitored more intensively than patients on standard treatment, with more frequent scans, blood tests and reviews. The second is that a trial is what is offered when nothing else can be done. That is simply not how the research pipeline works: many of the most important trials in cervical cancer have been in early disease, asking whether a smaller operation, a shorter radiation course or a lighter drug schedule could deliver the same result with fewer lasting effects.
What a trial cannot promise is benefit. That is the whole point of running one — if the answer were already known, the study would be unnecessary. A good conversation about trials starts from that honesty and works forward, which is also how we frame the choices on our advanced cervical cancer treatment page.
Did You Know? Every clinical trial conducted in India is required to be registered before it enrols its first participant, in the Clinical Trials Registry – India (CTRI), maintained by ICMR's National Institute of Medical Statistics. The register is public and searchable, which means you can look up the study you have been offered — its design, its sponsor, its sites and its stated outcomes — independently of whoever is describing it to you. Sources: Indian Council of Medical Research (ICMR); Clinical Trials Registry – India.
The Phases — and the Question Each One Asks
The phase tells you what stage of knowledge the treatment is at, how many people have received it before you, and how much is already known about its safety.
Phase I
Is It Safe, and at What Dose?
Small studies, often across several cancer types rather than one. The aim is to find a tolerable dose and describe the side effects. Visits are frequent and monitoring is close. Benefit is possible but is not the primary question being asked.
Phase II
Does It Do Anything Useful?
Larger, usually focused on one cancer type, and designed to see whether tumours actually respond. Many phase II studies in cervical cancer recruit women whose disease has returned or progressed after first-line treatment.
Phase III
Is It Better Than What We Do Now?
The decisive comparison, with participants allocated at random between the new approach and the current standard. These are the studies that change guidelines, and they are the reason today's standard treatment exists at all.
Phase IV
What Happens in the Real World?
Conducted after a treatment is already approved and in use, to track uncommon side effects and long-term outcomes across much larger numbers of people than any earlier phase could include.
De-escalation
Can We Do Less?
A category that matters enormously in cervical cancer, where many women are young. These trials ask whether a less radical operation, fewer nodes removed or a shorter treatment course gives the same result with less lasting harm.
Non-drug
Supportive and Quality-of-Life Studies
Not every trial tests a medicine. Some study exercise programmes, symptom management, sexual rehabilitation after pelvic radiation, or ways of delivering follow-up. These carry very little risk and are often overlooked.
Ask which phase a study is, and ask what the trial is comparing against. Those two answers frame everything else.
Who Is Likely to Be Eligible — and Why People Are Turned Down
Eligibility criteria look arbitrary from the outside and are anything but. They exist to make the result interpretable and to protect people for whom the risk would outweigh any possible gain. Being declared ineligible is not a judgement about you; it usually means the study cannot answer its question with your particular situation included.
Disease and prior treatment
Almost every protocol specifies a stage, a histological type, and exactly how many previous lines of treatment you may have had. A trial for women who have had no systemic treatment cannot include someone who has had two lines, and vice versa. Confirmed measurable disease on a recent scan is usually required as well.
Fitness and organ function
Performance status — a simple scale describing how much of the day you spend up and about — is checked, along with blood counts and kidney, liver and heart function. These thresholds exist because a body already under strain tolerates an unproven treatment poorly.
Biomarkers on the tumour
Many modern studies only accept participants whose tumour carries a particular feature — PD-L1 expression, a specific high-risk HPV type such as HPV 16 or HPV 18, or a molecular finding. This is why the screening process often asks for your original biopsy block, sometimes years after it was taken. Keep track of which laboratory holds it.
Practical and geographic reality
Trials require attendance on fixed dates at the recruiting centre, and phase I studies in particular can demand frequent visits. If the site is in another city, travel and accommodation become part of the decision. It is entirely reasonable to decline on those grounds — and better to weigh it honestly at the start than to withdraw halfway through.
Before you start looking: gather your histopathology report, the most recent scan report and images, a list of every treatment you have had with dates, and any biomarker testing already done. Screening for a trial cannot begin without them, and having them ready is often the difference between making a recruitment window and missing it. The cervical cancer overview explains what each of these documents is.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get the Options Laid Out Side by Side
Standard treatment, trial participation, or a combination — reviewed by surgical, radiation and medical oncology together. Same-week appointments across 7 NABH-accredited Hyderabad locations.
How to Find a Cervical Cancer Trial in India
There is no single hotline, but the search is more structured than most people expect, and it is worth doing yourself as well as through your doctor.
Start with the public registries
The Clinical Trials Registry – India lists studies running in the country, searchable by condition and by city. International registries list global studies, some of which have Indian sites. Read the eligibility section first; if you fail an inclusion criterion, nothing further in the listing matters.
Ask your oncologist to check, explicitly
Doctors do not always raise trials unprompted, particularly when standard treatment is working. Asking the direct question — “is there a study I would be eligible for, here or elsewhere?” — is legitimate, and no oncologist should take offence at it.
Look at the academic and regional cancer centres
Most cervical cancer trials in India run through large academic institutions and regional cancer centres, several of which are within reach of Hyderabad. A study open at one of those sites may accept a referral from your treating hospital.
Where CION fits in
We are honest about this: CION does not guarantee anyone a place in a trial, and we do not want a family travelling on the strength of an implied promise. What our team does is review your reports against published eligibility criteria, tell you plainly whether a study is worth pursuing, help assemble the documents a screening visit will demand, and coordinate the referral to the centre running it. If nothing fits, we say so and go back to the options on our cervical cancer treatment in Hyderabad page.
What You Are Entitled To as a Participant
These are not courtesies extended by the sponsor. They are requirements written into research ethics governance, and a study that is vague about any of them is a study to walk away from.
| Your right | What it means in practice | What to check |
|---|---|---|
| Written informed consent | A document in a language you read, explaining purpose, procedures, risks and alternatives | Take it home. Nobody may ask you to sign it in the same conversation in which you first hear about the study |
| Ethics committee approval | An independent committee has reviewed the protocol before a single participant was enrolled | Ask which committee approved it and when; the answer should be immediate |
| The right to withdraw | You may leave at any point, without giving a reason | Confirm that withdrawing does not affect your access to standard treatment and follow-up |
| Clarity about cost | What the study covers and what you or your insurer must pay should be itemised in writing | Ask specifically about scans, travel, hospital stay and treatment of side effects |
| Cover for trial-related injury | Provision for medical management and compensation if the study causes harm | This must be stated in the consent document, not merely promised verbally |
| Confidentiality | Your data is coded, and you are not identifiable in any publication | Ask who can access identifiable records and for how long they are kept |
| Being told what happens next | Access to the study result, and a plan for your care once the study ends | Ask what treatment you continue on if the study drug is stopped or the trial closes |
Take the consent document to a second doctor, or to a relative who reads carefully, before you sign. Nobody running a legitimate study will object to that.
Did You Know? ICMR's National Ethical Guidelines for Biomedical and Health Research Involving Human Participants set out that consent must be voluntary and informed, that participation is refusable and revocable at any time, and that neither refusing nor withdrawing may prejudice the care a person would otherwise receive. In other words, saying no to a trial cannot cost you your standard treatment — and if anyone implies otherwise, that alone is a reason to seek another opinion. Sources: Indian Council of Medical Research, National Ethical Guidelines; NCCN Clinical Practice Guidelines in Oncology — Cervical Cancer.
The Questions Worth Asking Before You Enrol
Most regret about trial participation comes not from the treatment but from unmet expectations — about travel, about cost, about what happens when the study ends. A short list of direct questions prevents nearly all of it.
- What is this trial comparing, and what would I receive if I did not join? If the standard option is good, that matters more than novelty.
- What phase is it, and how many people have already received this treatment? A phase III study sits on far more accumulated safety data than a phase I.
- How are participants allocated, and could I receive a placebo? In cancer trials a placebo is normally added to standard care rather than given instead of it — ask them to state that plainly.
- How often would I need to attend, and where? Convert that into travel time, days off work and family arrangements before agreeing.
- What exactly is paid for, and by whom? Get the answer itemised in writing, including scans and management of side effects.
- What happens if I have to stop, or if the trial closes early? There should be a clear plan for continuing your care.
- Who do I telephone at 2am if I feel unwell? A trial with a good answer to this question is usually a well-run trial.
Ask the same questions of the standard alternative too. Treatments that are already established come with their own schedule, cost and side-effect profile, and comparing the two honestly is the only way to make a decision you will still be comfortable with in six months.
Why Families Bring This Question to CION
A straight answer about what is available — including when the answer is that nothing fits.
Reports screened against real criteria
No promises we cannot keep
Tumour board review
Referral coordination
Free second opinion
45-minute detailed consultation
7 NABH-accredited Hyderabad locations
EMI facility & insurance accepted
4.8 / 5 Google rating
Take The Next Step
Ask the Question Rather Than Wondering
It takes one consultation to find out whether a study is relevant to you — and to understand your standard options properly either way.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Cervical Cancer Clinical Trials — Frequently Asked Questions
Will I be given a placebo instead of real treatment?
In cancer trials this is rare, and it is not how most studies are designed. Where an effective standard treatment already exists, it would be unethical to withhold it, so a placebo is normally given in addition to standard care in the comparison arm — meaning both groups receive established treatment and only the additional agent differs. A trial that used a placebo alone would have to be in a setting where no effective standard treatment exists, and that must be explained explicitly in the consent document. Ask the research team to state in plain words what you would receive in each arm, and do not sign until that answer is clear to you.
Do I have to pay to take part in a clinical trial in India?
Costs vary between studies and you should never assume. The treatment being tested and the tests done purely for research purposes are usually provided at no charge to the participant, funded by the sponsor. Routine care you would have had anyway, hospital admission, travel and accommodation may or may not be covered, and this differs between an academic study and an industry-sponsored one. Ask for a written, itemised list of what the study pays for and what you or your insurer must pay, including who covers the treatment of side effects. Legitimate research teams provide this without hesitation, and any reluctance to put it in writing is itself an answer.
How do I find out whether a cervical cancer trial is recruiting near Hyderabad?
Start with the Clinical Trials Registry - India, which is public, searchable by condition and city, and required to list studies conducted in the country. International registries carry global studies, some with Indian sites. Read the eligibility section before anything else. Then ask your oncologist the direct question of whether you would qualify for anything, here or at another centre — doctors do not always raise trials unprompted. Most cervical cancer studies in India run through large academic institutions and regional cancer centres, several within reach of Hyderabad, and a referral from your treating hospital is often the route in. CION will screen your reports against published criteria and coordinate that referral, but cannot guarantee a place.
Can I leave a clinical trial once I have started?
Yes, at any point and without giving a reason. This is a core protection in research ethics, and ICMR guidance is explicit that neither refusing to join nor withdrawing later may prejudice the care you would otherwise receive. In practice the team will ask whether you are willing to attend a final safety visit and to allow the data collected so far to be kept, but both requests are yours to accept or decline. You will then move back to standard treatment. If you feel any pressure to continue against your wishes, that is a reason to raise it with the ethics committee named in your consent document, or to seek a second opinion elsewhere.
Does being offered a trial mean my standard treatment has stopped working?
Not necessarily, and this assumption puts many women off unnecessarily. Trials run at every stage of cervical cancer, not only at the end of the line. Some of the most valuable studies in this disease have been in early-stage cancer, asking whether a less radical operation or a shorter treatment course achieves the same result with fewer permanent effects — questions that only matter to women who are expected to live for decades afterwards. Being offered a trial means your situation matches a question researchers are trying to answer. Whether it is right for you depends on the design, the travel, the schedule and how it compares with the standard option, which is exactly what a consultation is for.
Medical disclaimer: This page is general health information, reviewed by a CION oncologist. It is not a diagnosis, is not an offer of enrolment, and does not list or endorse any specific study. Which trials are open changes constantly, and eligibility can only be established by a screening assessment at the recruiting centre. Please discuss your situation with your treating team rather than relying on any website.